COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,244 Articles (22,733 medRxiv, 8,511 bioRxiv)

Most recent first Previous |  Page 4: Articles 31-40  | Next

COVID-19 Impact on Individuals with Type 1 and Type 2 Diabetes: Comparison of Pre- and Post-COVID-19 Hospitalizations for Diabetes-Related Amputation
Ionova, Y., Zhong, L., Vargas, R., Ma, Y., Wilson, L.
10.64898/2026.01.02.25342941 — Posted: 2026-01-03
Assessing the Impact of the Healthy Vaccinee Effect on COVID-19 Vaccine Effectiveness Estimates
Chemaitelly, H., Ayoub, H., Coyle, P., Tang, P., Hasan, M. R., YASSINE, H. M., Althani, A. A., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G. K., Al-Kuwari, M. G., Al-Romaihi, H. E., Al-Thani, M. H., Al-Khal, A., Bertollini, R., Butt, A. A., Abu-Raddad, L. J.
10.64898/2026.01.02.26343330 — Posted: 2026-01-03
Percutaneous Auricular Nerve Stimulation for Treating Post-COVID Fatigue (PAuSing-pCF)
Germann, M., Maffitt, N. J., Burton, O. A., Ashhad, A., Baker, A. M. E., Cherlin, S., Shahmandi, M., Charlton, N., Baker, A. S., Zaaimi, B., Ng, W.-F., Soteropoulos, D. S., Baker, S. N., Wason, J. M. S., Baker, M. R.
10.64898/2025.12.30.25343085 — Posted: 2026-01-02
Health impact assessment of ambient fine particulate matter 2.5 (PM2.5) decline during COVID-19 movement restrictions, India
Achanta, A. S., Aung, T. W.
10.64898/2025.12.31.25343296 — Posted: 2026-01-02
Health care resource consumption and corresponding economic burden in patients with acute cardiovascular diseases during the COVID-19 pandemic period
Moulaire, P., Delory, T., Rachas, A., Espagnacq, M., Khlat, M., le Coeur, S., Hejblum, G., Lapidus, N.
10.64898/2025.12.31.25343267 — Posted: 2026-01-02
Single-cell Tree-based Model for Genomic-Disease Association
Liu, Z., Niu, Y., Le, T., Chen, D. G., Su, Y., Zheng, Y.
10.64898/2025.12.31.697253 — Posted: 2026-01-02
Post-COVID impairment of memory T cell responses to community-acquired pathogens can be rectified by activating cellular metabolism
Carroll, D. D., Cira, K., Archer, J., Shapiro, J., Pen, U.-Y., Tieri, D., Leonor, L., Roofchayee, N. D., Yee, S. S., Wahab, M., Koralnik, I. J., Alverdy, J. C., Raman, A. S., Visvabharathy, L.
10.64898/2025.12.31.697156 — Posted: 2026-01-02
Peak Nasal SARS-CoV-2 and Influenza Viral Loads Relative to Symptom Onset, 2022-2025: Impact of Vaccination and Implications for Multiplexed Testing
Hunt, J. H., Damhorst, G. L., Parsons, R., Frediani, J., McLendon, K. B., Sullivan, J., Westbrook, A., Lam, W. A., Martin, G., Pollock, N.
10.64898/2025.12.23.25342938 — Posted: 2025-12-30
Apparent RSV-COVID interference is not robust to adjustment for shared testing propensity
Steier, J.
10.64898/2025.12.30.25343230 — Posted: 2025-12-30
Analytical comparison of over-the-counter multiplex tests for influenza A, influenza B and SARS-CoV-2
Lohsen, S., Hoy-Schulz, Y., Taing, A., Coughlin, B., Kim, J., Sullivan, J. A., Lam, W. A., Rao, A., Satola, S. W., Damhorst, G. L.
10.64898/2025.12.29.25343166 — Posted: 2025-12-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).